SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-22-000092
Filing Date
2022-08-12
Accepted
2022-08-12 08:32:45
Documents
47
Period of Report
2022-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-20220812.htm   iXBRL 8-K 38120
2 EX-99.1 phasebioq22022financialres.htm EX-99.1 63448
3 EX-99.2 phasebioq22022financials.htm EX-99.2 39378
7 phasebio2020logo.jpg GRAPHIC 27705
8 phasebioq22022financials001.jpg GRAPHIC 73653
9 phasebioq22022financials002.jpg GRAPHIC 249310
10 phasebioq22022financials003.jpg GRAPHIC 133873
11 phasebioq22022financials004.jpg GRAPHIC 124521
12 phasebioq22022financials005.jpg GRAPHIC 43193
13 phasebioq22022financials006.jpg GRAPHIC 136925
14 phasebioq22022financials007.jpg GRAPHIC 69205
15 phasebioq22022financials008.jpg GRAPHIC 52469
16 phasebioq22022financials009.jpg GRAPHIC 120635
17 phasebioq22022financials010.jpg GRAPHIC 121528
18 phasebioq22022financials011.jpg GRAPHIC 104737
19 phasebioq22022financials012.jpg GRAPHIC 43673
20 phasebioq22022financials013.jpg GRAPHIC 161718
21 phasebioq22022financials014.jpg GRAPHIC 140930
22 phasebioq22022financials015.jpg GRAPHIC 100448
23 phasebioq22022financials016.jpg GRAPHIC 75422
24 phasebioq22022financials017.jpg GRAPHIC 169572
25 phasebioq22022financials018.jpg GRAPHIC 148027
26 phasebioq22022financials019.jpg GRAPHIC 45129
27 phasebioq22022financials020.jpg GRAPHIC 127236
28 phasebioq22022financials021.jpg GRAPHIC 122900
29 phasebioq22022financials022.jpg GRAPHIC 107734
30 phasebioq22022financials023.jpg GRAPHIC 45158
31 phasebioq22022financials024.jpg GRAPHIC 139624
32 phasebioq22022financials025.jpg GRAPHIC 95155
33 phasebioq22022financials026.jpg GRAPHIC 100081
34 phasebioq22022financials027.jpg GRAPHIC 103350
35 phasebioq22022financials028.jpg GRAPHIC 55964
36 phasebioq22022financials029.jpg GRAPHIC 163509
37 phasebioq22022financials030.jpg GRAPHIC 150083
38 phasebioq22022financials031.jpg GRAPHIC 133003
39 phasebioq22022financials032.jpg GRAPHIC 139704
  Complete submission text file 0001169245-22-000092.txt   5307673

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20220812.xsd EX-101.SCH 1902
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20220812_lab.xml EX-101.LAB 25848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20220812_pre.xml EX-101.PRE 13581
41 EXTRACTED XBRL INSTANCE DOCUMENT phas-20220812_htm.xml XML 11435
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 221157943
SIC: 2834 Pharmaceutical Preparations